NCT05996835: Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI) |
|
|
| Recruiting | 2 | 320 | Europe, Canada, Japan, US, RoW | TIN816 70 mg lyophilisate powder, Placebo | Novartis Pharmaceuticals | Acute Kidney Injury Due to Sepsis | 12/25 | 02/26 | | |
RESCUE3, NCT03783884: A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation |
|
|
| Terminated | N/A | 223 | Europe, US | Lungpacer Diaphragm Pacing Therapy, Lungpacer DPTS, AeroPace System | Lungpacer Medical Inc. | Ventilator Induced Diaphragm Dysfunction | 12/22 | 01/23 | | |